Medicine and Health Sciences Commons^™

Rethinking Metabotropic Glutamate Receptor 5 Pathological Findings In Psychiatric Disorders: Implications For The Future Of Novel Therapeutics, Kelly A. Newell, Natalie Matosin

Faculty of Science, Medicine and Health - Papers: part A

Background Pharmacological modulation of metabotropic glutamate receptor 5 (mGluR5) is of marked interest as a novel therapeutic mechanism to treat schizophrenia and major depression. However, the status of mGluR5 in the pathophysiology of these disorders remains unknown. Discussion The majority of studies in the schizophrenia post-mortem brain indicate that total mGluR5 expression is unaltered. However, close examination of the literature suggests that these findings are superficial, and in actuality, a number of critical factors have not yet been considered; alterations may be highly dependent on brain region, neuronal population or molecular organisation in specific cellular compartments. A number of genetic …